News
DGAP-News: Nordex Group achieves order intake of 7.95 GW in fiscal year 2021
DGAP-News: Biotest AG: Biotest combats climate change through CO2-neutral production
![DGAP-News: AUTO1 Group SE: Q4 2021 Unit Sales and Purchases:](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNHd1Vnc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--67afbb0ba2ae2e3665d1c278fea40859c6f56cae/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AUTO1_Group_Logo.png?locale=us)
DGAP-News: AUTO1 Group SE: Q4 2021 Unit Sales and Purchases
![Startek Forms Special Committee in Response to Preliminary Non-Binding Acquisition Proposal by CSP Management Limited: https://mms.businesswire.com/media/20210317005065/en/865538/5/STARTEK_logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNDA4Vmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f21eaf986cc0ad1f82bf6c45c91ec1f1be7e234e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/STARTEK_logo.jpg?locale=us)
Startek Forms Special Committee in Response to Preliminary Non-Binding Acquisition Proposal by CSP Management Limited
The board of directors of Startek, Inc. (NYSE: SRT) has formed a special committee of independent directors that is authorized, among other things, to evaluate the non-binding proposal, dated
![Nordson Corporation Announces Segment Leadership Transition: https://mms.businesswire.com/media/20191120005506/en/198821/5/Nordson_large.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMWFFRWc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d66da3050dcf76ab21cd1ee045ce618d874e4521/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Nordson_large.jpg?locale=us)
Nordson Corporation Announces Segment Leadership Transition
Nordson Corporation (Nasdaq: NDSN) announced today that Greg Merk, executive vice president and Industrial Precision Solutions (IPS) segment leader, will be leaving the Company for new
![Arista Networks to Announce Q4 2021 Financial Results on Monday, February 14th 2022: https://mms.businesswire.com/media/20210406005937/en/336704/5/Arista_Logo_Transparent_Blue.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOUZUVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--94933b4b0e1a71c71cf4801a68c01fe7c7ba3d9d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Arista_Logo_Transparent_Blue.jpg?locale=us)
Arista Networks to Announce Q4 2021 Financial Results on Monday, February 14th 2022
Arista Networks, Inc. (NYSE:ANET) will release its financial results for the quarter ended December 31st, 2021 after U.S. markets close on Monday, February 14th, 2022. The results will be included
![Median Technologies Announces 2021 Revenue of €20.5 Million, Up 52%, and a Strengthened Cash Position of €39 Million: https://mms.businesswire.com/media/20200113005579/en/767035/5/Median_strapline.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd3BRSFE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6f39fecf5146be08cb4f343c975d6fff3d55bd8d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Median_strapline.jpg?locale=us)
Median Technologies Announces 2021 Revenue of €20.5 Million, Up 52%, and a Strengthened Cash Position of €39 Million
Regulatory News:
Median Technologies (ALMDT:PA) today announces its business activity indicators for the full year 2021. In 2021, the company’s business continued to grow at a rapid pace.
![MaaT Pharma Provides Business Objectives and Expected Milestones for 2022: https://mms.businesswire.com/media/20211211005036/en/729326/5/Nov_2018_new_version_MaaT_Pharma_logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK09sVnc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d25a561bb4e3c59d85340669bd72006bea493006/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Nov_2018_new_version_MaaT_Pharma_logo.jpg?locale=us)
MaaT Pharma Provides Business Objectives and Expected Milestones for 2022
Regulatory News:
MaaT Pharma (EURONEXT: MAAT - the “Company“), a French clinical-stage biotech and a pioneer in the development of microbiome-based ecosystem therapies dedicated to improving
DGAP-News: alstria office REIT-AG: Strong leasing results in Ratingen and Essen
![Brazilian Firms Act on Digital Transformation Plans in Response to Pandemic Disruptions: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBekQ3VlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--749a83316ab9c12370626f8e1fc75f740f454d82/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ISG_-28R-29_Logo.jpg?locale=us)
Brazilian Firms Act on Digital Transformation Plans in Response to Pandemic Disruptions
Digital transformation by Brazilian companies has rapidly advanced from concept to execution in recent years, especially as enterprises coped with the effects of the COVID-19 pandemic, according to
![ImmunoPrecise Antibodies Announces Grant of Stock Options: https://mms.businesswire.com/media/20210203005983/en/857090/5/ImmunoPrecise_logo_HZ_PMS.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeWtBVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--000b3982bf8e90eb30a01cca9649be03b0baae66/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ImmunoPrecise_logo_HZ_PMS.jpg?locale=us)
ImmunoPrecise Antibodies Announces Grant of Stock Options
IMMUNOPRECISE ANTIBODIES LTD. (“IPA” or the “Company”) (NASDAQ: IPA) (TSXV: IPA), a leader in full-service, therapeutic antibody discovery, today announced that on January 13, 2022 its board of
![Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.http://www.icatcher.com/wp-content/uploads/2012/04/Symantec.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12176/Symantec.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdEVCIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--1b3c47f309e54c35ff476143bba270ac36f5bc61/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Symantec.jpg?locale=us)
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
![Alliance Resource Partners, L.P. Announces Fourth Quarter 2021 Earnings Conference Call: https://mms.businesswire.com/media/20210412005210/en/1052735/5/LOGO_ARLP.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL2haVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d7bc43d58083f641040bdb8aee39cb1bee5b5f5c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/LOGO_ARLP.jpg?locale=us)
Alliance Resource Partners, L.P. Announces Fourth Quarter 2021 Earnings Conference Call
Alliance Resource Partners, L.P. (NASDAQ: ARLP) will report its fourth quarter 2021 financial results before the market opens on Monday, January 31, 2022. Alliance management will discuss these
DGAP-News: GEA Group Aktiengesellschaft: A capital market information
DGAP-News: CureVac Chief Technology Officer to Pursue New Career outside Biotech Industry
EQS-News: Nordea Bank Abp: Transaction in Own Shares
![Sensorion Updates on SENS-401 Phase 2 trial in Sudden Sensorineural Hearing Loss: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK0dxVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--df3db62501cd2dac51e6a4832a420790d1de65b6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/logo-sensorion2.jpg?locale=us)
Sensorion Updates on SENS-401 Phase 2 trial in Sudden Sensorineural Hearing Loss
Regulatory News:
Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and
![Lomiko Updates Private Placement: https://mms.businesswire.com/media/20210312005102/en/864833/5/LomikoLogo%28horizontal-colour%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMm8yVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b227a80ff15db7af463ab5c7bed9389990f976d9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/LomikoLogo-28horizontal-colour-29.jpg?locale=us)
Lomiko Updates Private Placement
Further to the press release dated January 7, 2022, Lomiko Metals Inc. (TSX.V: LMR) (“Lomiko Metals” or the “Company”), subject to the approval of the TSX Venture Exchange for a non-brokered
![EPR Properties Announces Tax Status of 2021 Distributions: https://mms.businesswire.com/media/20191216005756/en/351563/5/epr_hor_tag_color_pos_jpg.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK3JwRnc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ce1a1d07886968b774892358b264563207fa1632/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/epr_hor_tag_color_pos_.jpg?locale=us)
EPR Properties Announces Tax Status of 2021 Distributions
EPR Properties (NYSE: EPR) today announced the 2021 year-end tax reporting information for 2021 distributions made to shareholders. Shareholders are encouraged to consult with their personal tax
![Royal Gold Presenting at the TD Securities Global Mining Conference (Virtual): https://mms.businesswire.com/media/20191106005902/en/190143/5/Royal_Gold_Logo_-_no_shadow_-_Mar_07.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOXNsRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3d67b61076d94be393538149881101cfcf4f8cab/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Royal_Gold_Logo_-_no_shadow_-_Mar_07.jpg?locale=us)
Royal Gold Presenting at the TD Securities Global Mining Conference (Virtual)
Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company,” “we” or “our”) announced today that management will present in the TD Securities Global Mining
![Essex Reports Characteristics of 2021 Dividends: https://mms.businesswire.com/media/20191108005660/en/625771/5/Essex_Logo_Black_%28002%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK000RUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8ac7bfe485aea5b16eaa27ea6770ab98462dab33/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Essex_Logo_Black_-28002-29.jpg?locale=us)
Essex Reports Characteristics of 2021 Dividends
Essex Property Trust, Inc. (NYSE:ESS) announced today the income tax treatment for its 2021 distributions to shareholders. The 2021 distribution characteristics are as follows:
Common Stock –
![U.S. FDA Approves Pfizer’s CIBINQO® (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitishttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZHc9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--be1a2af5756eaa0acf5414ead3504a7e3ad45f8a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Pfizer.jpg?locale=us)
U.S. FDA Approves Pfizer’s CIBINQO® (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitis
Pfizer Inc. (NYSE: PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved CIBINQO® (abrocitinib), an oral, once-daily, Janus kinase 1 (JAK1) inhibitor, for
![ADTRAN, Inc. to Release Fourth Quarter 2021 Earnings on February 2, 2022: https://mms.businesswire.com/media/20200121005937/en/37691/5/ADTRAN_high-res.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd3paSGc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--68f0751fd5cdf23863464caabf4ce2c1e22e53d6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ADTRAN_high-res.jpg?locale=us)
ADTRAN, Inc. to Release Fourth Quarter 2021 Earnings on February 2, 2022
ADTRAN, Inc. (NASDAQ: ADTN) announced today that the Company will release its financial results for the fourth quarter 2021 after market close on Wednesday, February 2, 2022. The Company will